Clinical Trials Logo
  1. Home
  2. Laryngopharyngeal Reflux (LPR)
  3. NCT00641264

Quality of Life Validation in Laryngitis

Laryngopharyngeal Reflux (LPR) Clinical Trial

Official title:
Laryngopharyngeal Reflux Health Related Quality of Life (LPR-HRQL) Questionnaire Development and Psychometric Testing in Patients Receiving Omeprazole 20 mg Bid as Treatment for Laryngopharyngeal Reflux.

Clinical Trial Summary

The primary purpose of this study was to establish the psychometric properties of a new disease specific Quality of Life questionnaire, the LPR-HRQL. The specific properties of the questionnaire that were evaluated were: validity, reliability, and responsiveness to change (as a measure of treatment effect).

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00641264
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 4
Start date May 2001
Completion date June 2003
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05579587 - Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
Completed NCT01755221 - Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR